Jump to section
To create a happier and healthier world.
NeuroFlow is a behavioural health company improving healthcare through technology. Its cloud-based platform allows providers to monitor patients between visits, assess their mental health using AI-powered tools, and offer personalized recommendations.
Using AI and natural language processes, the company analyzes patient data and flags individuals at risk for issues like suicide, allowing providers to stay connected with their patients and intervene if necessary. A much-needed tool, NeuroFlow has partnered with various healthcare systems and providers, like Prudential, to provide support for vulnerable groups.
Recently the company acquired Owl, another digital behavioral health company, to expand its capabilities in measurement-based care. This acquisition strengthens its ability to help providers identify and manage patients' behavioural health needs more efficiently. As it grows, the company aims to have a big impact and play a vital role in providing better support for both patients and providers.
Freddie
Company Specialist at Welcome to the Jungle
Sep 2018
$2.3m
SEED
Christopher Molaro
(CEO)Graduated from The Wharton School with an M.B.A in Entrepreneurship/Entrepreneurial Studies. Previously a Fellow/Board Member at InSite as well as a Field Artillery Officer in the US Army.
Adam Pardes
(COO)Currently a Member of the Board of Advisors at Corventive Health and an Advisor at Groov. Previously they were a Sales Analyst at Sidecar and a Fellow/VP of Operations at InSITE.